Company Update2 Min Read InvestyWise NewsonMay 18, 2026 India Glycols Limited FY26 Results Showcase Strong Revenue and Profit Growth India Glycols Limited has reported a strong financial performance for the Full Year FY26, marked by an 11.8% rise in net revenue to ₹4,211…
Board Meeting1 Min Read InvestyWise NewsonMay 18, 2026 Strides Pharma Science Limited Financial Results for Year Ended March 31, 2026, and Dividend Declaration Strides Pharma Science Limited announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a…
Company Update2 Min Read InvestyWise NewsonMay 18, 2026 Strides Pharma Science Limited Strategic Board and Management Realignment Strides Pharma Science Limited has announced significant leadership changes effective June 1, 2026. As part of a succession planning framework…
Insider Trading / SAST1 Min Read InvestyWise NewsonMay 18, 2026 Nazara Technologies Limited Axana Estates LLP Increases Stake to 31.14% Axana Estates LLP, along with its Persons Acting in Concert (PAC), has increased its shareholding in Nazara Technologies Limited. Through an…
Company Update1 Min Read InvestyWise NewsonMay 18, 2026 KRBL Limited CFO Ashish Jain Discusses Q4 Financial Results with NDTV Profit KRBL Limited’s Chief Financial Officer, Ashish Jain, participated in a media interaction with NDTV Profit on May 18, 2026. The…
Company Update1 Min Read InvestyWise NewsonMay 18, 2026 Strides Pharma Science Limited Appointment of New Statutory Auditors Strides Pharma Science Limited has announced a transition in its statutory auditors. Upon the conclusion of the 36th Annual General Meeting in…
Company Update2 Min Read InvestyWise NewsonMay 18, 2026 Strides Pharma Science FY26 Operational PAT Grows 50% to ₹5,181 Million Strides Pharma Science Limited has announced robust financial results for FY26, with operational PAT surging 50% YoY to ₹5,181 million. Driven…
Company Update2 Min Read InvestyWise NewsonMay 18, 2026 Strides Pharma Science FY26 EBITDA Rises to ₹9,253 Million Strides Pharma Science Limited announced a robust financial performance for the fiscal year ended March 31, 2026. The company reported an…
Corporate Action2 Min Read InvestyWise NewsonMay 18, 2026 Strides Pharma Science Limited Annual Financial Results and Dividend Announcement for FY 2026 Strides Pharma Science Limited has announced its audited financial results for the quarter and financial year ended March 31, 2026. The Board…
Company Results1 Min Read InvestyWise NewsonMay 18, 2026 Strides Pharma Science FY2026 Financial Results and Dividend Declaration Strides Pharma Science Limited announced its financial results for the quarter and year ended March 31, 2026. The company reported a…